anmelden
Dow Jones 30 Industrial
49.696,41
PKT
+87,25
PKT
+0,18
%
Indikation*
49.704,47
PKT
+95,31
PKT
+0,19
%
Offiziell
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu Dow Jones 30 Industrial-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 14.03.12 | Nike overweight | Barclays Capital | |
| 14.03.12 | Microsoft halten | Independent Research GmbH | |
| 13.03.12 | Amazon buy | UBS AG | |
| 13.03.12 | Visa outperform | RBC Capital Markets | |
| 12.03.12 | Nike buy | Stifel, Nicolaus & Co., Inc. | |
| 12.03.12 | Nike sell | McAdams Wright Ragen Inc. | |
| 12.03.12 | Apple kaufen | Euro am Sonntag | |
| 12.03.12 | Chevron overweight | Barclays Capital | |
| 09.03.12 | Microsoft halten | Der Aktionär | |
| 09.03.12 | Apple outperform | Exane-BNP Paribas SA | |
| 09.03.12 | American Express underperform | RBC Capital Markets | |
| 09.03.12 | Apple outperform | RBC Capital Markets | |
| 09.03.12 | Honeywell outperform | RBC Capital Markets | |
| 08.03.12 | Apple buy | Deutsche Bank Securities | |
| 08.03.12 | Apple overweight | Morgan Stanley | |
| 08.03.12 | Apple buy | UBS AG | |
| 07.03.12 | Apple overweight | Barclays Capital | |
| 07.03.12 | Apple overweight | Barclays Capital | |
| 07.03.12 | American Express equal-weight | Barclays Capital | |
| 05.03.12 | Coca-Cola neutral | UBS AG | |
| 05.03.12 | Johnson Johnson kaufen | Die Actien-Börse | |
| 02.03.12 | Caterpillar buy | Sarasin Research | |
| 01.03.12 | Visa neutral | UBS AG | |
| 01.03.12 | Apple outperform | RBC Capital Markets | |
| 01.03.12 | JPMorgan Chase overweight | Barclays Capital | |
| 01.03.12 | Chevron buy | Deutsche Bank Securities | |
| 29.02.12 | Apple buy | UBS AG | |
| 29.02.12 | Apple overweight | Barclays Capital | |
| 28.02.12 | Boeing neutral | UBS AG | |
| 28.02.12 | Procter Gamble halten | Independent Research GmbH | |
| 28.02.12 | Walmart equal-weight | Barclays Capital | |
| 28.02.12 | Chevron halten | Independent Research GmbH | |
| 27.02.12 | Procter Gamble neutral | UBS AG | |
| 27.02.12 | Salesforce overweight | Barclays Capital | |
| 27.02.12 | Procter Gamble buy | Sarasin Research | |
| 27.02.12 | Salesforce outperform | RBC Capital Markets | |
| 27.02.12 | Procter Gamble outperform | RBC Capital Markets | |
| 24.02.12 | Salesforce buy | Stifel, Nicolaus & Co., Inc. | |
| 24.02.12 | Salesforce buy | Needham & Company, LLC | |
| 24.02.12 | Chevron neutral | Sarasin Research |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.